161 related articles for article (PubMed ID: 21081654)
21. Genetic factors in drug metabolism.
Belle DJ; Singh H
Am Fam Physician; 2008 Jun; 77(11):1553-60. PubMed ID: 18581835
[TBL] [Abstract][Full Text] [Related]
22. Can the Internet help to meet the challenges in ADME and e-ADME?
Van de Waterbeemd H; De Groot M
SAR QSAR Environ Res; 2002; 13(3-4):391-401. PubMed ID: 12184380
[TBL] [Abstract][Full Text] [Related]
23. Brazilian cohort and genes encoding for drug-metabolizing enzymes and drug transporters.
Kim V; Wal TV; Nishi MY; Montenegro LR; Carrilho FJ; Hoshida Y; Ono SK
Pharmacogenomics; 2020 Jun; 21(9):575-586. PubMed ID: 32486903
[No Abstract] [Full Text] [Related]
24. Pharmacogenomics, ancestry and clinical decision making for global populations.
Ramos E; Doumatey A; Elkahloun AG; Shriner D; Huang H; Chen G; Zhou J; McLeod H; Adeyemo A; Rotimi CN
Pharmacogenomics J; 2014 Jun; 14(3):217-22. PubMed ID: 23835662
[TBL] [Abstract][Full Text] [Related]
25. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
[TBL] [Abstract][Full Text] [Related]
26. Pharmacogenetics: has it reached the clinic?
Schwartz JB
J Gend Specif Med; 2002; 5(2):13-8. PubMed ID: 11974670
[TBL] [Abstract][Full Text] [Related]
27. Positive selection drives population differentiation in the skeletal genes in modern humans.
Wu DD; Zhang YP
Hum Mol Genet; 2010 Jun; 19(12):2341-6. PubMed ID: 20233747
[TBL] [Abstract][Full Text] [Related]
28. Development of a broad-based ADME panel for use in pharmacogenomic studies.
Brown AM; Renaud Y; Ross C; Hansen M; Mongrain I; Valois D; Carleton BC; Hayden MR; Dubé MP; Tardif JC; Phillips MS
Pharmacogenomics; 2014 Jun; 15(9):1185-95. PubMed ID: 25141894
[TBL] [Abstract][Full Text] [Related]
29. Metabolic polymorphisms and cancer susceptibility.
Smith G; Stanley LA; Sim E; Strange RC; Wolf CR
Cancer Surv; 1995; 25():27-65. PubMed ID: 8718512
[TBL] [Abstract][Full Text] [Related]
30. Natural selection has driven population differentiation in modern humans.
Barreiro LB; Laval G; Quach H; Patin E; Quintana-Murci L
Nat Genet; 2008 Mar; 40(3):340-5. PubMed ID: 18246066
[TBL] [Abstract][Full Text] [Related]
31. MDR1 gene polymorphisms and clinical relevance.
Li YH; Wang YH; Li Y; Yang L
Yi Chuan Xue Bao; 2006 Feb; 33(2):93-104. PubMed ID: 16529292
[TBL] [Abstract][Full Text] [Related]
32. Toward individualized pharmaceutical care of East Asians: the value of genetic testing for polymorphisms in drug-metabolizing genes.
Morrison A; Levy R
Pharmacogenomics; 2004 Sep; 5(6):673-89. PubMed ID: 15335288
[TBL] [Abstract][Full Text] [Related]
33. Molecular basis of ethnic differences in drug disposition and response.
Xie HG; Kim RB; Wood AJ; Stein CM
Annu Rev Pharmacol Toxicol; 2001; 41():815-50. PubMed ID: 11264478
[TBL] [Abstract][Full Text] [Related]
34. Human loci involved in drug biotransformation: worldwide genetic variation, population structure, and pharmacogenetic implications.
Maisano Delser P; Fuselli S
Hum Genet; 2013 May; 132(5):563-77. PubMed ID: 23354977
[TBL] [Abstract][Full Text] [Related]
35. Potential genetic causes of heterogeneity of treatment effects.
Goldstein DB; Need AC; Singh R; Sisodiya SM
Am J Med; 2007 Apr; 120(4 Suppl 1):S21-5. PubMed ID: 17403378
[TBL] [Abstract][Full Text] [Related]
36. Pharmacogenetics of drug metabolizing enzymes in Brazilian populations.
Cerda A; Hirata MH; Hirata RD
Drug Metabol Drug Interact; 2014; 29(3):153-77. PubMed ID: 24744305
[TBL] [Abstract][Full Text] [Related]
37. Copy number variation profiling in pharmacogenetics CYP-450 and GST genes in Colombian population.
Ramírez B; Niño-Orrego MJ; Cárdenas D; Ariza KE; Quintero K; Contreras Bravo NC; Tamayo-Agudelo C; González MA; Laissue P; Fonseca Mendoza DJ
BMC Med Genomics; 2019 Jul; 12(1):110. PubMed ID: 31324178
[TBL] [Abstract][Full Text] [Related]
38. Worldwide Distribution of Cytochrome P450 Alleles: A Meta-analysis of Population-scale Sequencing Projects.
Zhou Y; Ingelman-Sundberg M; Lauschke VM
Clin Pharmacol Ther; 2017 Oct; 102(4):688-700. PubMed ID: 28378927
[TBL] [Abstract][Full Text] [Related]
39. [Genetic polymorphism (sequence variation) of foreign substance-metabolizing enzymes and their significance in environmental medicine. Statement of the Commission "Methods and Quality Assurance in Environmental Medicine"].
Commission on Methods and Quality Assurance in Environmental Medicine
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2004 Nov; 47(11):1115-23. PubMed ID: 15549207
[No Abstract] [Full Text] [Related]
40. Pharmacogenetics of drug-metabolizing enzymes in US Hispanics.
Claudio-Campos K; Duconge J; Cadilla CL; Ruaño G
Drug Metab Pers Ther; 2015 Jun; 30(2):87-105. PubMed ID: 25431893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
